These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37821375)

  • 1. [A case of rectal cancer with immune thrombocytopenic purpura that achieved a complete response to continued chemotherapy with eltrombopag].
    Tanaka Y; Kuroda H; Honma K; Wakaki K
    Nihon Shokakibyo Gakkai Zasshi; 2023; 120(10):852-857. PubMed ID: 37821375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful eltrombopag treatment of severe refractory thrombocytopenia in chronic myelomonocytic leukemia: Two cases reports: A CARE-compliant article.
    Gao Y; Gong M; Zhang C; Kong X; Ma Y
    Medicine (Baltimore); 2017 Oct; 96(43):e8337. PubMed ID: 29069007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic rectal neuroendocrine carcinoma presenting with treatment-refractory immune thrombocytopenia: A case report and literature review.
    Bancheno WM; Adidam SR; Melaku MA
    Medicine (Baltimore); 2022 Jul; 101(29):e29616. PubMed ID: 35866784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Severe thrombocytopenia refractory to platelet transfusions, secondary to abciximab readministration, in a patient previously diagnosed with idiopathic thrombocytopenic purpura. A possible etiopathogenic link].
    Méndez TC; Díaz O; Enríquez L; Baz JA; Fernández F; Goicolea J
    Rev Esp Cardiol; 2004 Aug; 57(8):789-91. PubMed ID: 15282070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia.
    González-López TJ; Pascual C; Álvarez-Román MT; Fernández-Fuertes F; Sánchez-González B; Caparrós I; Jarque I; Mingot-Castellano ME; Hernández-Rivas JA; Martín-Salces M; Solán L; Beneit P; Jiménez R; Bernat S; Andrade MM; Cortés M; Cortti MJ; Pérez-Crespo S; Gómez-Núñez M; Olivera PE; Pérez-Rus G; Martínez-Robles V; Alonso R; Fernández-Rodríguez A; Arratibel MC; Perera M; Fernández-Miñano C; Fuertes-Palacio MA; Vázquez-Paganini JA; Gutierrez-Jomarrón I; Valcarce I; de Cabo E; Sainz A; Fisac R; Aguilar C; Paz Martínez-Badas M; Peñarrubia MJ; Calbacho M; de Cos C; González-Silva M; Coria E; Alonso A; Casaus A; Luaña A; Galán P; Fernández-Canal C; Garcia-Frade J; González-Porras JR
    Am J Hematol; 2015 Mar; 90(3):E40-3. PubMed ID: 25400215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Concomitant use of romiplostim and chemotherapy for advanced rectal cancer associated with idiopathic thrombocytopenic purpura].
    Yamada M; Shinzaki S; Nishida T; Yamada T; Fujinaga T; Yakushijin T; Tatsumi T; Iijima H; Hiramatsu N; Tsujii M; Takehara T
    Nihon Shokakibyo Gakkai Zasshi; 2014 Mar; 111(3):521-8. PubMed ID: 24598096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A Case of Platinum-Resistant Recurrent Ovarian Cancer with Idiopathic Thrombocytopenic Purpura].
    Hirayama T; Kin S; Ohta M; Saburo T; Kimoto S
    Gan To Kagaku Ryoho; 2021 Jun; 48(6):821-824. PubMed ID: 34139731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic thrombocytopenic purpura complicated by intracranial hemorrhage in a 78-year-old male.
    Kobayashi H; Sagawa K; Watanabe N; Morito T; Kazuta Y; Takase Y; Kasukawa R
    Fukushima J Med Sci; 1995 Jun; 41(1):79-86. PubMed ID: 8606045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A Case of Idiopathic Thrombocytopenic Purpura during Adjuvant Chemotherapy for Colon Cancer].
    Takahara Y; Ozawa S; Ogasawara T; Shida T; Nomura S; Sato Y; Takahashi M
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2145-7. PubMed ID: 26805292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neutrophil recovery by eltrombopag treatment in a patient with adult-onset autoimmune neutropenia and immune thrombocytopenia].
    Tokunaga M; Yamada M; Kondo A; Mishima M; Yoshikawa S; Inoue S; Morita T; Tominaga N
    Rinsho Ketsueki; 2018; 59(3):310-314. PubMed ID: 29618690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial.
    Bussel JB; Provan D; Shamsi T; Cheng G; Psaila B; Kovaleva L; Salama A; Jenkins JM; Roychowdhury D; Mayer B; Stone N; Arning M
    Lancet; 2009 Feb; 373(9664):641-8. PubMed ID: 19231632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of recurrent rectal cancer with idiopathic thrombocytopenic purpura showing rapid progression, suggesting disseminated intravascular coagulopathy].
    Ohira G; Miyauchi H; Tohma T; Kuboshima M; Yoneyama Y; Matsubara H
    Gan To Kagaku Ryoho; 2012 Jan; 39(1):139-42. PubMed ID: 22241370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of gray platelet syndrome masked by immune thrombocytopenia at presentation.
    Mizuno N; Kanamori E; Saito H; Murakami N; Tojo N; Tohda S
    Acta Haematol; 2014; 132(2):163-5. PubMed ID: 24577417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of perioperative administration of eltrombopag in a patient with idiopathic thrombocytopenic purpura undergoing cardiovascular surgery].
    Shomura S; Katayama Y; Kusagawa H; Komada T
    Kyobu Geka; 2014 Mar; 67(3):203-6. PubMed ID: 24743530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suspected Immune Thrombocytopenic Purpura Induced by Lenalidomide for the Treatment of Myelodysplastic Syndrome with Deletion of Chromosome 5q: A Case Report.
    Furukawa H; Nomura J; Kobayashi M; Abe S; Takeda T; Oka Y; Shirota Y; Kodera T; Okitsu Y; Takahashi S; Murakami K; Kameoka J
    Tohoku J Exp Med; 2023 Jan; 259(2):113-119. PubMed ID: 36450481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portal vein thrombosis during eltrombopag treatment for immune thrombocytopenic purpura in a patient with liver cirrhosis due to hepatitis C viral infection.
    Kawano N; Hasuike S; Iwakiri H; Nakamura K; Ozono Y; Kusumoto H; Nagata K; Kikuchi I; Yoshida S; Kuriyama T; Yamashita K; Muranaka T; Kawaguchi T; Sata M; Okamura T; Ueda A; Shimoda K
    J Clin Exp Hematop; 2013; 53(2):151-5. PubMed ID: 23995112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficiency and safety of eltrombopag for multi-line failed Chinese patients with immune thrombocytopenia: cases with decreased megakaryocyte response well from single-center experience.
    Liu Q; Shen Y; Li Y; Hu H; Liu W; Zhao Y; Dong H; Shen Y; Zhou Y; Ye B; Wu D
    Immunol Res; 2022 Feb; 70(1):67-74. PubMed ID: 34669176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired amegakaryocytic thrombocytopenia after durvalumab administration.
    Suyama T; Hagihara M; Kubota N; Osamura Y; Shinka Y; Miyao N
    J Clin Exp Hematop; 2021 Mar; 61(1):53-57. PubMed ID: 33431742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Maintenance of efficacy and its predictors after discontinuation of eltrombopag in adults with primary immune thrombocytopenia].
    Sun HP; You JH; Chen QS; Wang J; Li JM
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jan; 44(1):32-37. PubMed ID: 36987720
    [No Abstract]   [Full Text] [Related]  

  • 20. Graves' disease-induced immune thrombocytopenic purpura in an African female: a case report.
    Agyapong KO; Folson AA; Fiador K; Kootin-Sanwu C; Tufuor M; Bampoh SA; Fiscian H; Wonkyi R
    J Med Case Rep; 2023 Apr; 17(1):122. PubMed ID: 37016396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.